Log in

Relevant bibliographies by topics / Green Technologies in Pharma / Journal articles

To see the other types of publications on this topic, follow the link: Green Technologies in Pharma.

Journal articles on the topic 'Green Technologies in Pharma'

Author: Grafiati

Published: 2 June 2025

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Green Technologies in Pharma.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Hugar, G. Rohan, Dr M. L. Pruthvi, and Dr M. K. Mahesh. "Natural Green Synthesis of Silver Nanoparticles using Leaf Extract of Guazuma Ulmifolia Lam and Analysis of its Antimicrobial Property." International Journal for Research in Applied Science and Engineering Technology 11, no. 12 (2023): 512–22. http://dx.doi.org/10.22214/ijraset.2023.57370.

Full text

Abstract:

Abstract: In the field of life science, nanoparticles are one of the leading adverse technologies. Here, the particles are seen in nanometers of 1–100 nm. In small-size particles, many useful applications are seen in the fields of medicine, pharma, agriculture, and many more industry sectors. In the present study, Guazuma ulmifolia, a member of the Malvavceae family, was a test plant. In this study, silver nanoparticles were synthesised from plant extract. Characterization using SEM, XRD, FTIR, and UV spectra confirmed the presence of nanoparticles. Silver nanoparticle sizes were measured usin

APA, Harvard, Vancouver, ISO, and other styles

2

Foff, Erin P., Jeffrey L. Cummings, Maria-Eugenia Soto-Martin, Pierre Tariot, Bradley McEvoy, and Srdjan Stankovic. "427 - HARMONY study: pimavanserin significantly reduces risk of relapse of dementia-related psychosis." International Psychogeriatrics 32, S1 (2020): 143. http://dx.doi.org/10.1017/s104161022000280x.

Full text

Abstract:

AbstractDementia-related psychosis (DRP) is common among patients with Alzheimer’s disease (AD), Parkinson’s disease (PD), dementia with Lewy bodies (DLB), frontotemporal dementia (FTD), and vascular dementia (VaD) and is associated with poor outcomes. HARMONY (NCT03325556) was a Phase 3, placebo-controlled, randomized, relapse-prevention study evaluating the efficacy and safety of pimavanserin for treating hallucinations and delusions associated with DRP. Patients with dementia and moderate-severe psychosis received open-label (OL) pimavanserin for 12 weeks. Patients with a sustained response

APA, Harvard, Vancouver, ISO, and other styles

3

Kamran, Alam Ansari*. "Green Chemistry in Pharmaceutical Drug Development: A Comprehensive Review." International Journal of Pharmaceutical Sciences 3, no. 5 (2025): 3513–17. https://doi.org/10.5281/zenodo.15476577.

Full text

Abstract:

The increasing demand for sustainable practices in the pharmaceutical industry has led to the growing adoption of green chemistry—a science dedicated to designing environmentally friendly chemical processes and products. This comprehensive review explores the evolution, principles, and applications of green chemistry in pharmaceutical drug development. Key focus areas include waste reduction, atom economy, safer solvents, energy efficiency, and renewable feedstocks. The paper discusses how these principles are applied across various stages of drug development, from synthesis to delivery,

APA, Harvard, Vancouver, ISO, and other styles

4

ROUHI, A. MAUREEN. "GREEN CHEMISTRY FOR PHARMA." Chemical & Engineering News 80, no. 16 (2002): 30–33. http://dx.doi.org/10.1021/cen-v080n016.p030.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

SARROPOULOU, Virginia, Eleni MALOUPA, and Katerina GRIGORIADOU. "In vitro direct organogenesis of the Cretan dittany (Origanum dictamnus L.), an important threatened Greek endemic species." Notulae Botanicae Horti Agrobotanici Cluj-Napoca 50, no. 2 (2022): 12715. http://dx.doi.org/10.15835/nbha50212715.

Full text

Abstract:

Dittany of Crete (Origanum dictamnus L.) is a threatened medicinal-aromatic plant of Lamiaceae family which is a local endemic to the Island of Crete, Greece. Its high culinary use and increasing demand in the pharma, perfumery, cosmetic and food industry along with its overexploitation from its natural habitat has threatened this species and has necessitated its large-scale production for industrial exploitations using advanced technologies. Micropropagation is considered a good tool for ex situ conservation of endangered species with reduced populations in the wild, low germination rates and

APA, Harvard, Vancouver, ISO, and other styles

6

Mittal, Swati, Bhavisha Wadhwani, and Monika Lakhani. "Innovations in Pharma Packaging Technologies." Journal of Young Pharmacists 13, no. 3 (2021): 197–200. http://dx.doi.org/10.5530/jyp.2021.13.41.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Jackson, L., F. Mugeta, E. Mcneeley, et al. "AB1250 OUTPATIENT FOLLOW-UP AFTER AN EMERGENCY DEPARTMENT VISIT FOR ACUTE GOUT FLARE." Annals of the Rheumatic Diseases 82, Suppl 1 (2023): 1851.3–1852. http://dx.doi.org/10.1136/annrheumdis-2023-eular.1701.

Full text

Abstract:

BackgroundPatients with acute gout are frequently treated in the emergency department (ED). Appropriate outpatient follow-up for an acute flare after an ED visit is variable and has not been systematically examined.ObjectivesWe aimed to determine the characteristics of patients with gout treated in EDs, the nature of their ED visits, and to determine the types and rates of outpatient follow-up after an ED visit for an acute gout flare.MethodsThis study was conducted at one academic medical center that serves patients at 3 EDs (2 urban, 1 suburban) and 1 urban urgent care center. Patients were

APA, Harvard, Vancouver, ISO, and other styles

8

Christiana Bridell, ACS staff. "Pharma roundtable awards green chemistry grants." C&EN Global Enterprise 98, no. 43 (2020): 37. http://dx.doi.org/10.1021/cen-09843-acsnews3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Hodgson, John. "Biotech's Platform Technologies Lure Big Pharma." Nature Biotechnology 13, no. 9 (1995): 945–47. http://dx.doi.org/10.1038/nbt0995-945.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

G. Nair, Dr Gopkakumar. "INERTIA TO ADOPT DIGITAL TECHNOLOGIES IN PHARMA." Indian Drugs 59, no. 07 (2022): 5–6. http://dx.doi.org/10.53879/id.59.07.p0005.

Full text

Abstract:

Dear Reader, During the turn of the century and early millennium, when the potential of online pharmacies was predicted, there was widespread hue and cry including the regulators.The regulator agencies had cautioned against any proposal for online selling of medicines and had declared such actions, illegal and not compliant to the provisions of the Drugs and Cosmetics Act. AIOCD and other associations of wholesale and retail chemists had vehemently opposed the proposals. Over the years, online Pharmacies have not only come to stay but have flourished.

APA, Harvard, Vancouver, ISO, and other styles

11

RITTER, STEVE. "GREEN CHEMISTRY AGS, pharma initiative awards first grant." Chemical & Engineering News 85, no. 7 (2007): 19. http://dx.doi.org/10.1021/cen-v085n007.p019a.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Pandey, Abhishek. "Blockchain for Pharmaceutical Industry: Present, Past and Future." INTERANTIONAL JOURNAL OF SCIENTIFIC RESEARCH IN ENGINEERING AND MANAGEMENT 09, no. 03 (2025): 1–9. https://doi.org/10.55041/ijsrem42252.

Full text

Abstract:

To better understand the characteristics and evolution of research in Blockchain Technologies for pharma sector, this work reports results from the survey study targeting the Blockchain technologies for pharma industry (BTPI). Despite the existing survey studies on BTPI, our contribution in this work is to provide information to researchers and practitioners willing to enter the Blockchain field, being a source of information to strengthen the research field, guide new studies, and motivate new collaboration among research groups. A survey of Blockchain technologies for pharma industry is cond

APA, Harvard, Vancouver, ISO, and other styles

13

Metz, Katja, and Michael Seadle. "Green publishing with green technologies." Library Hi Tech 30, no. 3 (2012): 381–83. http://dx.doi.org/10.1108/07378831211266528.

Full text

Abstract:

PurposeIf libraries truly want to be ecologically responsible, they need also to consider the impact of book and journal production on the environment. This paper seeks to address this issue.Design/methodology/approachThe methodology looks at energy consumption in journal production.FindingsElectronic publication does not produce a perfectly green product, but more of a dark green one with many aspects where energy costs could be saved. A genuinely ecologically friendly publication process requires conscious planning and determination.Originality/valueUsers can stop demanding paper as well as

APA, Harvard, Vancouver, ISO, and other styles

14

Panic, Manuela, Kristina Radosevic, Marina Cvjetko Bubalo, et al. "Green solvents for green technologies." Journal of Biotechnology 256 (August 2017): S11—S12. http://dx.doi.org/10.1016/j.jbiotec.2017.06.040.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Redovnikovic, Ivana Radojcic, Manuel Panic, Marina Cvjetko Bubalo, Kristina Radosevic, and Visnja Gaurina Srcek. "Green solvents for green technologies." Journal of Biotechnology 280 (August 2018): S10. http://dx.doi.org/10.1016/j.jbiotec.2018.06.336.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Cvjetko Bubalo, Marina, Senka Vidović, Ivana Radojčić Redovniković, and Stela Jokić. "Green solvents for green technologies." Journal of Chemical Technology & Biotechnology 90, no. 9 (2015): 1631–39. http://dx.doi.org/10.1002/jctb.4668.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

J, Yuktha H., Gururaj S. Kulkarni, Athmaja Shetty, and Padmaa M. Paarakh. "Technologies in the Pharmaceutical Industries and Medical Health Care." International Journal of Information technology and Computer Engineering, no. 26 (October 28, 2022): 26–38. http://dx.doi.org/10.55529/ijitc.26.26.38.

Full text

Abstract:

This review aims to illustrate upcoming technological developments in the pharmaceutical industries and healthcare facilities may look in the near future. In order to achieve this, we examine recent technologies and advanced medical developments in healthcare as well as in the pharma industries. Such as Artificial intelligence which provides an understanding between process parameters and different formulations. Blockchain is a sophisticated database that stores data in a way that makes it impossible to alter or hack the system. Clouding Technology enhances the drug discovery process. In the F

APA, Harvard, Vancouver, ISO, and other styles

18

J, Yuktha H., Gururaj S. Kulkarni, Athmaja Shetty, and Padmaa M. Paarakh. "Technologies in the Pharmaceutical Industries and Medical Health Care." International Journal of Information technology and Computer Engineering, no. 26 (October 28, 2022): 28–38. http://dx.doi.org/10.55529/ijitc.26.28.38.

Full text

Abstract:

This review aims to illustrate upcoming technological developments in the pharmaceutical industries and healthcare facilities may look in the near future. In order to achieve this, we examine recent technologies and advanced medical developments in healthcare as well as in the pharma industries. Such as Artificial intelligence which provides an understanding between process parameters and different formulations. Blockchain is a sophisticated database that stores data in a way that makes it impossible to alter or hack the system. Clouding Technology enhances the drug discovery process. In the F

APA, Harvard, Vancouver, ISO, and other styles

19

Sara Cottle. "Proposals sought for grants for green chemistry pharma research." C&EN Global Enterprise 102, no. 13 (2024): 37–38. http://dx.doi.org/10.1021/cen-10213-acsnews8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Hickman, Elizabeth. "Sustainability in Pharma Manufacturing: Strategic Benefits of Going Green." Genetic Engineering & Biotechnology News 45, no. 5 (2025): 38–39. https://doi.org/10.1089/gen.45.05.18.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Cowan, Andrew J., Margot Pont, Blythe Duke Sather, et al. "Safety and Efficacy of Fully Human BCMA CAR T Cells in Combination with a Gamma Secretase Inhibitor to Increase BCMA Surface Expression in Patients with Relapsed or Refractory Multiple Myeloma." Blood 138, Supplement 1 (2021): 551. http://dx.doi.org/10.1182/blood-2021-154170.

Full text

Abstract:

Abstract Background: Chimeric antigen receptor T cells (CAR T cells) targeting B cell maturation antigen (BCMA) have demonstrated rapid and deep responses among patients with multi-agent refractory multiple myeloma (MM). BCMA is shed from tumor cells mediated through enzymatic cleavage by the gamma secretase complex, and tumor cells with low levels of BCMA could potentially escape CAR T recognition. We showed previously that gamma secretase inhibitors (GSI) increase BCMA surface density on tumor cells, decrease soluble BCMA levels, and enhance efficacy of BCMA CAR T cells in an immunodeficient

APA, Harvard, Vancouver, ISO, and other styles

22

Kala, Harneet Kaur, Rajendra Mehta, Kamal Kumar Sen, Roshni Tandey, and Vivekananda Mandal. "Strategizing method optimization of microwave-assisted extraction of plant phenolics by developing standard working principles for universal robust optimization." Analytical Methods 9, no. 13 (2017): 2089–103. http://dx.doi.org/10.1039/c7ay00098g.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Sandeep, Ramanamuni. "Driving Digital Transformation in the Pharma Industry." INTERNATIONAL JOURNAL OF INNOVATIVE RESEARCH AND CREATIVE TECHNOLOGY 6, no. 4 (2020): 1–5. https://doi.org/10.5281/zenodo.15087585.

Full text

Abstract:

Manufacturing and supply chain transformation through digital technology is best illustrated in the pharmaceutical industries. This paper investigates critical initiatives of digitalization in pharmaceutical companies, including integrated engineering, paperless manufacturing, and digital supply chains. These initiatives are driven by emerging technologies such as AI, IoT, blockchain, and big data analytics. The paper reveals how digital tools drive predictive maintenance and enhanced decision-making while boosting agility across manufacturing lines. Insights from the market project increase i

APA, Harvard, Vancouver, ISO, and other styles

24

Ettinger, Sabine, Judit Erdos, and Cecilia De Villiers. "VP37 Patient Involvement In EUnetHTA Assessments (Non-Pharma Technologies)." International Journal of Technology Assessment in Health Care 35, S1 (2019): 85. http://dx.doi.org/10.1017/s0266462319003106.

Full text

Abstract:

IntroductionPatients can provide valuable experience on living with diseases, health-related quality of life, various therapies and relevant outcomes. Their input and perspectives can be helpful in complementing health technology assessment (HTA) processes. The European Network for HTA (EUnetHTA), funded by the European Commission, aims to further advance and standardise patient involvement processes in order to add to the quality and applicability of HTAs and to allow capability building.MethodsDifferent methods for patient involvement in HTAs on non-pharmaceutical technologies were tested: P

APA, Harvard, Vancouver, ISO, and other styles

25

Veleva, Vesela, and Berkeley W. Cue Jr. "Benchmarking green chemistry adoption by “big pharma” and generics manufacturers." Benchmarking: An International Journal 24, no. 5 (2017): 1414–36. http://dx.doi.org/10.1108/bij-01-2016-0003.

Full text

Abstract:

Purpose The purpose of this paper is to benchmark current adoption of green chemistry (GC) practices by the innovative and generic pharmaceutical companies and examine the drivers, barriers and future opportunities. Design/methodology/approach The authors examined publicly available data for the top 10 “big pharma” and top ten generic drug manufacturers. Using the IQ Green Chemistry working group framework for effective GC programs, they scored each of the 20 companies in seven key areas. Findings The study finds that generic drug companies have not embraced GC at the level of the innovative p

APA, Harvard, Vancouver, ISO, and other styles

26

Mrunal Joshi. "Analysis of Industry 4.0 and Transformative Trends in Pharma." Journal of Information Systems Engineering and Management 10, no. 3 (2025): 1325–35. https://doi.org/10.52783/jisem.v10i3.7783.

Full text

Abstract:

Pharma 4.0 represents a disruptive force that is revolutionizing the pharmaceutical industry. It is presenting newer opportunities for innovation, and patient-centric care. The smart manufacturing driven by advanced technologies like Artificial Intelligence (AI), Robotics, Internet of Things (IoT), Big Data Analytics (BDA) seeks to integrate digital technologies and automation to create smart, connected manufacturing facilities. The given study examined the applications of AI, big data analytics, and IoT across drug development and marketing processes. The study has used qualitative analysis t

APA, Harvard, Vancouver, ISO, and other styles

27

Clark, Birgit, and Ruth Burstall. "Blockchain, IP and the pharma industry—how distributed ledger technologies can help secure the pharma supply chain." Journal of Intellectual Property Law & Practice 13, no. 7 (2018): 531–33. http://dx.doi.org/10.1093/jiplp/jpy069.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Schledjewski, Ralf, Silvia Lloret Pertegas, Yannick Blößl, et al. "High Performance Green Composites for Green Technologies." Key Engineering Materials 742 (July 2017): 271–77. http://dx.doi.org/10.4028/www.scientific.net/kem.742.271.

Full text

Abstract:

Composite materials do offer freedom to design a material fitting best to the requirements of a given application. In case of fiber reinforced polymers especially the low weight in combination with other favorable properties, e.g. high mechanical performance, are the driving force for their application. Materials from renewable resources are of high interest if sustainability is aimed. In this paper, in a holistic approach a green composite is aimed to be used in a rotor blade for wind energy production. The challenging topic for this approach is to identify a possibility to gain a thermoset r

APA, Harvard, Vancouver, ISO, and other styles

29

Schulz, A. "Green methanol, part of Uhde's green technologies." Chemie Ingenieur Technik 94, no. 9 (2022): 1209–10. http://dx.doi.org/10.1002/cite.202255339.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

T., Sajna. "Indian Pharma—Some Challenges and Acceptances." Management Insight - The Journal of Incisive Analysers 16, no. 01 (2020): 38–40. http://dx.doi.org/10.21844/mijia.16.1.7.

Full text

Abstract:

Business enterprises are an important organ of society. The impact of a business enterprise’s motive will directly affect society, which includes environment, consumers, employees, suppliers, and other stakeholders. Big pharma companies face a huge drop in revenue from blockbuster drugs coming off patent. Without generating revenues through sales, these companies will struggle to fund the development of new life-saving drugs. Artificial intelligence (AI) can be a powerful tool in the pharmaceutical industry’s research and development. So with the help of modern technologies, pharmaceutical com

APA, Harvard, Vancouver, ISO, and other styles

31

Surowiecki, Andrzej, Michał Kruszyński, and Stanisław Ślusarczyk. "Green technologies pavement construction." Logistics and Transport 59, no. 2 (2023): 87–108. http://dx.doi.org/10.26411/83-1734-2015-2-56-5-24.

Full text

Abstract:

The article deals with the problem of the negative impact of road traffic on the environment. An attempt has been made to justify the need to modify the current technical and material requirements for the construction of road pavements in view of the dynamic growth of road traffic and the increase in freight transport. The attention is focused on the effectiveness of modern and environmentally friendly asphalt pavements. The presented technologies include recycling, polymer modified asphalts, asphalts modified with rubber granules, examples of environmentally friendly pavement constructions an

APA, Harvard, Vancouver, ISO, and other styles

32

Malheiro, Vera, Joana Duarte, Francisco Veiga, and Filipa Mascarenhas-Melo. "Exploiting Pharma 4.0 Technologies in the Non-Biological Complex Drugs Manufacturing: Innovations and Implications." Pharmaceutics 15, no. 11 (2023): 2545. http://dx.doi.org/10.3390/pharmaceutics15112545.

Full text

Abstract:

The pharmaceutical industry has entered an era of transformation with the emergence of Pharma 4.0, which leverages cutting-edge technologies in manufacturing processes. These hold tremendous potential for enhancing the overall efficiency, safety, and quality of non-biological complex drugs (NBCDs), a category of pharmaceutical products that pose unique challenges due to their intricate composition and complex manufacturing requirements. This review attempts to provide insight into the application of select Pharma 4.0 technologies, namely machine learning, in silico modeling, and 3D printing, i

APA, Harvard, Vancouver, ISO, and other styles

33

Ciurczak, Emil W. "NIRS is having a renaissance; but not all the pieces are moving at the same speed." NIR news 30, no. 3 (2019): 12–14. http://dx.doi.org/10.1177/0960336019837140.

Full text

Abstract:

Near-infrared has been a staple in many industries for over four decades but has lagged behind in the other, consumer-based industries. One reason is that the Pharma industry is highly regulated and producers have been hesitant to attempt any changes. Since 2004, numerous guidances from the FDA and EMA, along with guidelines from the International Council for Harmonisation, have encouraged and, in reality, given permission to the Pharma industry to enter the 21st century. Together with financial pressures, available technologies are moving the industry to new levels of quality and safety (and

APA, Harvard, Vancouver, ISO, and other styles

34

Lallas, Efthymios N., Ilias Santouridis, Georgios Mountzouris, Vassilis C. Gerogiannis, and Anthony Karageorgos. "An SQWRL-Based Method for Assessing Regulatory Compliance in the Pharmaceutical Industry." Applied Sciences 12, no. 21 (2022): 10923. http://dx.doi.org/10.3390/app122110923.

Full text

Abstract:

Nowadays, data integrity has become a critical issue in the pharmaceutical regulatory landscape, one that requires data to be compliant to ALCOA principles (i.e., data must be Attributable, Legible, Contemporaneous, Original, and Accurate). In this paper, we propose a method which exploits semantic web technologies to represent pharma manufacturing data in a unified manner and evaluate in a systematic manner their ALCOA compliance. To this purpose, in the context of a pharma manufacturing environment, a data integrity ontology (DIOnt) is proposed to be utilized as the basis for the semantic re

APA, Harvard, Vancouver, ISO, and other styles

35

CHIDOLUO VITUS, OKECHUKWU. "THE IMPACT OF TECHNOLOGICAL ADVANCEMENTS ON PHARMA EDUCATION AND DRUG DISCOVERY." Pharma Scope and Advances in Drug Sciences 01, no. 02 (2024): 01–03. https://doi.org/10.64347/3066-2583/psads.007.

Full text

Abstract:

Technological advancements have revolutionized the landscape of pharmaceutical education and drug discovery. This paper explores the profound impact of these advancements, encompassing areas like artificial intelligence (AI), high-throughput screening, robotics, and big data analytics. It examines how these technologies are transforming pharmaceutical education curricula, enhancing drug discovery processes, accelerating timelines, and improving drug safety and efficacy. Furthermore, the paper delves into the challenges associated with integrating these technologies, including the need for skil

APA, Harvard, Vancouver, ISO, and other styles

36

Kim, Jungbin, and Seungkwan Hong. "Future green seawater desalination technologies." Journal of the Korean Society of Water and Wastewater 34, no. 6 (2020): 403–10. http://dx.doi.org/10.11001/jksww.2020.34.6.403.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Pandey, Vimal Chandra, and Gordana Gajić. "Green Technologies for Soil Remediation." Bulletin of Environmental Contamination and Toxicology 108, no. 3 (2022): 387–88. http://dx.doi.org/10.1007/s00128-022-03485-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Avramchikova, Nadezhda, Ivan Rozhnov, Tatyana Zelenskaya, Olga Maslova, and Vyacheslav Avramchikov. "Circular economy and “green technologies”." E3S Web of Conferences 291 (2021): 02014. http://dx.doi.org/10.1051/e3sconf/202129102014.

Full text

Abstract:

The feature of the circular economy is the restorative and closed nature of the production cycle with the “green” nature-like technologies application which reduce greenhouse gas emissions, slow down the temperature rise on the planet and preserve the environment. The circular economy approaches correspond to the concept of goal-setting of the United Nations Organization in the mainstream of sustainable socio-economic development and are widely used in the countries of the European Union. As a part of their research, scientists have defined a circular economy as the economy which involves the

APA, Harvard, Vancouver, ISO, and other styles

39

Fierascu, Radu Claudiu, Roxana Ioana Brazdis, Irina Fierascu, Anda Maria Baroi, Toma Fistos, and Sorin Marius Avramescu. "Green Technologies for Wastewater Depollution." Proceedings 57, no. 1 (2020): 30. http://dx.doi.org/10.3390/proceedings2020057030.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Yu Konyuhov, V., A. M. Gladkih, I. I. Galyautdinov, and Ya D. Severina. "Economic aspects of green technologies." IOP Conference Series: Earth and Environmental Science 350 (November 15, 2019): 012036. http://dx.doi.org/10.1088/1755-1315/350/1/012036.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Gozalvez, Javier. "Green Radio Technologies [Mobile Radio." IEEE Vehicular Technology Magazine 5, no. 1 (2010): 9–14. http://dx.doi.org/10.1109/mvt.2009.935550.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Chong, Mei Fong, Dominic C. Y. Foo, Denny K. S. Ng, and Nishanth Chemmangattuvalappil. "Green Technologies for Sustainable Processes." Process Safety and Environmental Protection 92, no. 6 (2014): 487–88. http://dx.doi.org/10.1016/j.psep.2014.09.006.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Chaouki, Jamal, and Jaber Shabanian. "Editorial:Fluidization for Emerging Green Technologies." Powder Technology 316 (July 2017): 1–2. http://dx.doi.org/10.1016/j.powtec.2017.05.035.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Chowdhary, Pankaj, and Ram Naresh Bharagava. "Green technologies and environmental sustainability." Environment, Development and Sustainability 22, no. 3 (2019): 2699–701. http://dx.doi.org/10.1007/s10668-018-00304-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Hao Ngo, Huu, Xuan-Thanh Bui, Long D. Nghiem, and Wenshan Guo. "Green technologies for sustainable water." Bioresource Technology 317 (December 2020): 123978. http://dx.doi.org/10.1016/j.biortech.2020.123978.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Chu, Won-Shik, Doo-Man Chun, and Sung-Hoon Ahn. "Research advancement of green technologies." International Journal of Precision Engineering and Manufacturing 15, no. 6 (2014): 973–77. http://dx.doi.org/10.1007/s12541-014-0424-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

CHIDOLUO VITUS, OKECHUKWU. "ENHANCING STUDENT LEARNING IN DRUG DEVELOPMENT THROUGH ADVANCED PHARMA EDUCATION." Pharma Scope and Advances in Drug Sciences 01, no. 02 (2024): 01–02. https://doi.org/10.64347/3066-2583/psads.010.

Full text

Abstract:

The burgeoning field of drug development demands a workforce equipped with advanced scientific knowledge, critical thinking skills, and collaborative abilities. This paper explores the vital role of advanced pharma education in enhancing student learning within drug development, emphasizing the integration of cutting-edge technologies, interdisciplinary approaches, and practical training. It examines the current landscape of pharmaceutical education, identifies areas requiring improvement, and proposes innovative strategies to bridge the gap between academia and industry. By fostering a deeper

APA, Harvard, Vancouver, ISO, and other styles

48

Withers, Daniel Pashang. "Brewing Green Beer." Texas A&M Law Review 8, no. 4 (2021): 9–26. http://dx.doi.org/10.37419/lr.v8.arg.2.

Full text

Abstract:

New beer brewing technologies provide brewers with options to produce beer in more eco-friendly, less resource-intensive ways; however, as brewers adopt these technologies, they may find themselves straddling between the regulatory schemes of the Alcohol and Tobacco Tax and Trade Bureau (“TTB”) and the Food and Drug Administration (“FDA”). The two agencies have divided control over beers based on their ingredients, which places some beers under the TTB’s purview as “malted beverages” and others under the FDA’s purview. These distinctions have implications for the regulatory hurdles that brewer

APA, Harvard, Vancouver, ISO, and other styles

49

Withers, Daniel Pashang. "Brewing Green Beer." Texas A&M Law Review 8, no. 4 (2021): 9–26. http://dx.doi.org/10.37419/lr.v8.arg.2.

Full text

Abstract:

New beer brewing technologies provide brewers with options to produce beer in more eco-friendly, less resource-intensive ways; however, as brewers adopt these technologies, they may find themselves straddling between the regulatory schemes of the Alcohol and Tobacco Tax and Trade Bureau (“TTB”) and the Food and Drug Administration (“FDA”). The two agencies have divided control over beers based on their ingredients, which places some beers under the TTB’s purview as “malted beverages” and others under the FDA’s purview. These distinctions have implications for the regulatory hurdles that brewer

APA, Harvard, Vancouver, ISO, and other styles

50

Utaminingsih, Adijati, Sony, John, and Linda Kusuma. "Green Business Behaviour, Green Technologies, and Sustainability in SMEs." International Journal of Economics and Business Administration VIII, Issue 1 (2020): 417–24. http://dx.doi.org/10.35808/ijeba/435.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!